What is Sense Neuro Diagnostics?
Sense Neuro Diagnostics operates at the intersection of advanced engineering and clinical neurology. The company specializes in non-invasive, real-time monitoring solutions designed to improve outcomes for patients suffering from strokes and traumatic brain injuries. By developing proprietary technology capable of rapid detection and effective triage, Sense addresses critical gaps in current diagnostic workflows. Their portfolio includes innovations for identifying ischemic strokes and intracerebral hemorrhages, providing clinicians with the actionable data necessary for timely intervention. As a leader in neuro-diagnostics, the company is currently advancing its technology through rigorous clinical validation, aiming to set a new standard for continuous brain injury monitoring in acute care settings.
How much funding has Sense Neuro Diagnostics raised?
Sense Neuro Diagnostics has raised a total of $1.6M across 3 funding rounds:
Private Equity
$250K
Private Equity
$1.3M
Debt
$76K
Private Equity (2017): $250K with participation from Accelerant
Private Equity (2017): $1.3M led by Queen City Angels
Debt (2021): $76K supported by PPP
Key Investors in Sense Neuro Diagnostics
Accelerant
Accelerant Dayton is a digital agency specializing in SEO consultancy, site optimization, and user retention strategies for high-growth enterprises.
Queen City Angels
QCA Ventures is an investor network focused on supporting entrepreneurs and early-stage companies through mentorship, deal sourcing, and strategic guidance.
PPP
Public-Private Partnership
What's next for Sense Neuro Diagnostics?
With the support of its recent capital raise, Sense Neuro Diagnostics is poised to scale its operational capabilities and finalize its ongoing pivotal trials. The strategic focus remains on the commercialization of its triage technology and the integration of its monitoring systems into standard hospital protocols. By prioritizing clinical evidence and regulatory milestones, the company is building a robust foundation for long-term market penetration. Future growth will likely center on expanding the diagnostic utility of its platform, potentially addressing a broader spectrum of neurological conditions and solidifying its role as a cornerstone of modern neuro-critical care infrastructure.
See full Sense Neuro Diagnostics company page
